Insulet Overview
Insulet Target Price
Analysts' 12-month price predictions for PODD.
Share Price
$173.42
Average Target Price
$226.00
30.3% upside
30.3% upside1 analysts in the last 4 months
High: $226 | Low: $226
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-21 | Canaccord GenuityKyle Rose | $226 | 30.3% upside |  |
| 2023-01-06 | Morgan Stanley | $320 | 84.5% upside | |
| 2022-11-03 | Piper SandlerMatt O'Brien | $340 | 96.1% upside | |
| 2022-10-17 | Morgan StanleyCecilia Furlong | $273 | 57.4% upside | |
| 2022-08-23 | Raymond JamesJayson Bedford | $280 | 61.5% upside | |
| 2022-03-03 | Bank of America SecuritiesTravis Steed | $300 | 73% upside | |
| 2022-02-02 | UBSMatthew Taylor | $325 | 87.4% upside | |
| 2022-01-31 | OppenheimerSteven Lichtman | $275 | 58.6% upside | |
| 2021-12-06 | Canaccord GenuityKyle Rose | $330 | 90.3% upside | |
| 2021-11-08 | Berenberg BankRavi Misra | $295 | 70.1% upside | |
| 2021-11-05 | CitigroupJoanne Wuensch | $350 | 101.8% upside | |
| 2021-10-12 | JefferiesRaj Denhoy | $340 | 96.1% upside | |
| 2021-07-21 | Cowen & Co.Josh Jennings | $310 | 78.8% upside | |
| 2021-05-07 | ThriventJP McKim | $250 | 44.2% upside | |